Yo ho ho and a barrel of biology! Ahoy there, mates! Avast, it's time to set sail on a voyage of scientific discovery, as the news ripples through the vast ocean of the pharmaceutical world. Prepare to be amazed as I batten down the hatches and regale you with the tale of a grand, yet unexpected acquisition.
In the latest plot twist, pharmaceutical giant Merck has emerged as the cunning pirate, sporting an impressive treasure chest filled with $680 million doubloons. And who, you ask, did they set their sights on? None other than the mighty Harpoon Therapeutics!
